Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: Use of population impact measures

BMC Medicine

Volumn 4, Issue , 2006, Pages

  Heller, Richard F ^a   Gemmell, Islay ^a   Edwards, Richard ^b   Buchan, Iain ^a   Awasthi, Shally ^c   Volmink, James A ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

^d UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; DEATH; DIRECTLY OBSERVED THERAPY; HEALTH CARE COST; HUMAN; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; RISK REDUCTION; SHORT COURSE THERAPY; TUBERCULOSIS;

COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; HUMANS; INCIDENCE; INDIA; PREVALENCE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 33846706254     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-4-35     Document Type: Article

References (32)

1. Heller RF Dobson AJ Disease impact number and population impact number: a population perspective to measures of risk and benefit BMJ 2000 321 950-952 1118742 11030691 10.1136/bmj.321.7266.950
2. Heller RF Edwards R McElduff P Implementing guidelines in primary care: can population impact measures help? BMC Public Health 2003 3 7 149228 12542840 10.1186/1471-2458-3-7
3. Heller RF Buchan I Edwards R Lyratzopoulos G McElduff P St Leger S Communicating risks at the population level: Application of population impact numbers BMJ 2003 327 1162-1165 261823 14615346 10.1136/ bmj.327.7424.1162
4. Coker R Atun R McKee M Untangling Gordian knots: Improving tuberculosis control through the development of 'programme theories' Int J Health Plann Manage 2004 19 217-226 10.1002/hpm.759 15387089
5. Volmink J Matchaba P Garner P Directly observed therapy and treatment adherence Lancet 2000 355 1345-1350 10.1016/S0140-6736(00)02124-3 10776760
6. Directorate General of Health Services. Tuberculosis Control India 2005 http://www.tbcindia.org
7. Murray CJ Salomon JA Modeling the impact of global tuberculosis control strategies Proc Natl Acad Sci USA 1998 95 13881-13886 24946 9811895 10.1073/pnas.95.23.13881
8. Dye C Garnett GP Sleeman K Williams BG Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy Lancet 1998 352 1886-1891 10.1016/ S0140-6736(98)03199-7 9863786
9. Bleed D Dye C Raviglione MC Dynamics and control of the global tuberculosis epidemic Curr Opin Pulm Med 2000 6 174-179 10.1097/ 00063198-200005000-00002 10782699
10. Murray CJ Salomon JA Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding Int J Tuberc Lung Dis 1998 2 S9-15 9755959
11. Golub JE Mohan CI Comstock GW Chaisson RE Active case finding of tuberculosis: Historical perspective and future prospects Int J Tuberc Lung Dis 2005 9 1183-1203 16333924
12. Volmink J Garner P Directly observed therapy for treating tuberculosis The Cochrane Library 2003 1
13. World Health Organisation Global Tuberculosis Control: Surveillance, Planning, Financing Geneva, Switzerland WHO 2006
14. Baltussen R Floyd K Dye C Cost effectiveness analysis of strategies for tuberculosis control in developing countries BMJ 2005 331 1364 1309642 16282379 10.1136/bmj.38645.660093.68
15. Zaidi AKM Awasthi S deSilva HJ Burden of infectious diseases in South Asia BMJ 2004 328 811-815 383379 15070639 10.1136/bmj.328.7443.811
16. Jagota P Mahadev B Srikantaramu N Balasangameshwara V Sreenivas T Case-finding in diostrict tuberculosis programme: Potential and perfromance Ind J Tub 1998 45 39-46
17. Fox W Ellard GA Mitchison DA Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-with relevant subsequent publications International Journal of Tuberculosis and Lung Disease 1999 3 S231-S279
18. Dye C Scheele S Dolin P Pathania V Raviglione MC Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project JAMA 1999 282 677-686 10.1001/jama.282.7.677 10517722
19. Barton S Clinical Evidence: The International Source of the Best Available Evidence for Effective Health Care London: BMJ Publishing Group 7 2004
20. World Health Organisation Treatment Of Tuberculosis: Guidelines For Natinal Programmes. WHO/TB/97.220 Geneva, World Health Organisation 1997
21. Dye C Watt CJ Bleed DM Williams BG What is the limit to case detection under the DOTS strategy for tuberculosis control? Tuberculosis (Edinb) 2003 83 35-43 10.1016/S1472-9792(02)00056-2 12758187
22. Demissie M Lindtjorn B Berhane Y Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia BMC Public Health 2002 2 23 130033 12296975 10.1186/1471-2458-2-23
23. Volmink J Garner P Directly observed therapy for treating tuberculosis Cochrane Database Syst Rev 2006 CD003343 16625579
24. Coast J Is economic evaluation in touch with society's health values? BMJ 2004 329 1233-1236 529373 15550430 10.1136/bmj.329.7476.1233
25. Stone PW Schackman BR Neukermans CP Olchanski N Greenberg D Rosen AB A synthesis of cost-utility analysis literature in infectious disease Lancet Infect Dis 2005 5 383-391 10.1016/S1473-3099(05)70142-0 15919624
26. Heller RF Gemmell I Wilson EC Fordham R Smith RD Using economic analyses for local priority setting: The population cost-impact approach Appl Health Econ Health Policy 2006 5 45-54 10.2165/00148365-200605010-00006 16774292
27. Fahey T Griffiths S Peters TJ Evidence based purchasing: Understanding results of clinical trials and systematic reviews British Medical Journal 1995 311 1056-1059 7580661
28. McGettigan P Sly K O'Connell D Hill S Henry D The Effects of Information Framing on the Practices of Physicians Journal of General Internal Medicine 1999 14 633-642 1496755 10571710 10.1046/ j.1525-1497.1999.09038.x
29. Heller RF Sandars JE Patterson L McElduff P GPs' and physicians' interpretation of risks, benefits and diagnostic test results Fam Pract 2004 21 155-159 10.1093/fampra/cmh209 15020384
30. Dobrow MJ Goel V Upshur RE Evidence-based health policy: Context and utilisation Soc Sci Med 2004 58 207-217 10.1016/S0277-9536(03)00166-7 14572932
31. Singer PA Martin DK Giacomini M Purdy L Priority setting for new technologies in medicine: Qualitative case study BMJ 2000 321 1316-1318 27534 11090513 10.1136/bmj.321.7272.1316
32. Elliott H Popay J How are policy makers using evidence? Models of research utilisation and local NHS policy making J Epidemiol Community Health 2000 54 461-468 10.1136/jech.54.6.461 10818123